113 related articles for article (PubMed ID: 36585863)
1. Verteporfin-loaded microparticles for radiosensitization of preclinical lung and breast metastatic spine cancer.
Akinduro OO; Suarez-Meade P; Roberts M; Tzeng SY; Sarabia-Estrada R; Schiapparelli P; Norton ES; Gokaslan ZL; Anastasiadis PZ; Guerrero-Cázares H; Green JJ; Quiñones-Hinojosa A
J Neurosurg Spine; 2023 Apr; 38(4):481-493. PubMed ID: 36585863
[TBL] [Abstract][Full Text] [Related]
2. Determination of the migration effect and molecular docking of verteporfin in different subtypes of breast cancer cells.
Wei C; Li X
Mol Med Rep; 2020 Nov; 22(5):3955-3961. PubMed ID: 32901856
[TBL] [Abstract][Full Text] [Related]
3. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
4. Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation.
Wei C; Li X
BMC Cancer; 2020 Oct; 20(1):1042. PubMed ID: 33121449
[TBL] [Abstract][Full Text] [Related]
5. Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models.
Barrette AM; Ronk H; Joshi T; Mussa Z; Mehrotra M; Bouras A; Nudelman G; Jesu Raj JG; Bozec D; Lam W; Houldsworth J; Yong R; Zaslavsky E; Hadjipanayis CG; Birtwistle MR; Tsankova NM
Neuro Oncol; 2022 May; 24(5):694-707. PubMed ID: 34657158
[TBL] [Abstract][Full Text] [Related]
6. Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment.
Song M; Zhu L; Zhang L; Ge X; Cao J; Teng Y; Tian R
Mol Pharm; 2024 May; 21(5):2340-2350. PubMed ID: 38546166
[TBL] [Abstract][Full Text] [Related]
7. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of yes-associated protein suppresses migration, invasion, and metastasis in non-small cell lung cancer in vitro and in vivo.
Takeda T; Tsubaki M; Genno S; Matsuda T; Yamamoto Y; Kimura A; Shimizu N; Nishida S
Clin Exp Med; 2022 May; 22(2):221-228. PubMed ID: 34196881
[TBL] [Abstract][Full Text] [Related]
9. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
Brouwer NJ; Konstantinou EK; Gragoudas ES; Marinkovic M; Luyten GPM; Kim IK; Jager MJ; Vavvas DG
Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):3. PubMed ID: 33798262
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin Suppresses YAP-Induced Glycolysis in Breast Cancer Cells.
Chen H; Zhang LF; Miao Y; Xi Y; Li X; Liu MF; Zhang M; Li B
J Invest Surg; 2023 Dec; 36(1):2266732. PubMed ID: 37828756
[TBL] [Abstract][Full Text] [Related]
11. "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines".
Sanna L; Piredda R; Marchesi I; Bordoni V; Forcales SV; Calvisi DF; Bagella L
Chem Biol Interact; 2019 Oct; 312():108813. PubMed ID: 31494105
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the safety of ovarian cortex autotransplantation: cancer cells are purged completely from human ovarian tissue fragments by pharmacological inhibition of YAP/TAZ oncoproteins.
Mulder CL; Eijkenboom LL; Beerendonk CCM; Braat DDM; Peek R
Hum Reprod; 2019 Mar; 34(3):506-518. PubMed ID: 30597012
[TBL] [Abstract][Full Text] [Related]
13. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway.
Li Y; Yang S; Yang S
Cells; 2022 Apr; 11(8):. PubMed ID: 35456040
[TBL] [Abstract][Full Text] [Related]
14. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
Brodowska K; Al-Moujahed A; Marmalidou A; Meyer Zu Horste M; Cichy J; Miller JW; Gragoudas E; Vavvas DG
Exp Eye Res; 2014 Jul; 124():67-73. PubMed ID: 24837142
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.
Zhou X; Chen N; Xu H; Zhou X; Wang J; Fang X; Zhang Y; Li Y; Yang J; Wang X
J Hematol Oncol; 2020 Jun; 13(1):77. PubMed ID: 32546241
[TBL] [Abstract][Full Text] [Related]
16. [Verteporfin inhibits proliferation, invasion and migration of MDA-MB-231 human breast cancer cells by down-regulating the expression of Yes-associated protein].
Jiang Y; Liu Y; Zhang Z; Yang J; Ye X; Jin Q; Chen T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1223-1227. PubMed ID: 29089081
[TBL] [Abstract][Full Text] [Related]
17. Verteporfin regulates corneal neovascularization through inhibition of YAP protein activation.
Lin L; Zheng Y; Li Q; Sun Y; Huang Y; Liang L; Xu L; Zhao YE
Exp Eye Res; 2024 Jan; 238():109747. PubMed ID: 38072353
[TBL] [Abstract][Full Text] [Related]
18. SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
Isfort I; Cyra M; Elges S; Kailayangiri S; Altvater B; Rossig C; Steinestel K; Grünewald I; Huss S; Eßeling E; Mikesch JH; Hafner S; Simmet T; Wozniak A; Schöffski P; Larsson O; Wardelmann E; Trautmann M; Hartmann W
Clin Cancer Res; 2019 Jun; 25(12):3718-3731. PubMed ID: 30814111
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex.
Wei H; Wang F; Wang Y; Li T; Xiu P; Zhong J; Sun X; Li J
Cancer Sci; 2017 Mar; 108(3):478-487. PubMed ID: 28002618
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells.
Zhou W; Lim A; Elmadbouh OHM; Edderkaoui M; Osipov A; Mathison AJ; Urrutia R; Liu T; Wang Q; Pandol SJ
Free Radic Biol Med; 2024 Feb; 212():493-504. PubMed ID: 38184120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
